{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:22Z","timestamp":1786988122097,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ20H180006"],"award-info":[{"award-number":["LQ20H180006"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H180004"],"award-info":[{"award-number":["LY21H180004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271076"],"award-info":[{"award-number":["82271076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejpb.2025.114691","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:03:19Z","timestamp":1741176199000},"page":"114691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Peptide-based hydrogel co-assembled with antibody-drug for enhanced retinal cell uptake and attenuated experimental autoimmune uveitis"],"prefix":"10.1016","volume":"210","author":[{"given":"Mali","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114691_b0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00281-014-0433-9","article-title":"Autoimmune and autoinflammatory mechanisms in uveitis","volume":"36","author":"Lee","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejpb.2025.114691_b0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2013.02.001","article-title":"Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions","volume":"34","author":"Klaassen","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114691_b0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00281-008-0106-7","article-title":"Mechanisms of leukocyte migration across the blood-retina barrier","volume":"30","author":"Crane","year":"2008","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ejpb.2025.114691_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cells10010064","article-title":"The Impact of Oxidative Stress on Blood-Retinal Barrier Physiology in Age-Related Macular Degeneration","volume":"10","author":"Tisi","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ejpb.2025.114691_b0025","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.3390\/ijms24108796","article-title":"Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications","volume":"24","author":"Ramos","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2025.114691_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640473","article-title":"Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings","volume":"12","author":"Takeuchi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2025.114691_b0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"de Smet","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114691_b0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","article-title":"Fundamentals of Care for Uveitis International Consensus Group, Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative","volume":"125","author":"Dick","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2025.114691_b0045","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10238-022-00954-6","article-title":"Pathogenesis and current therapies for non-infectious uveitis","volume":"23","author":"Wu","year":"2023","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ejpb.2025.114691_b0050","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114691_b0055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/imm.13479","article-title":"Retinal microglia: Functions and diseases","volume":"166","author":"Fan","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.ejpb.2025.114691_b0060","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1159\/000531156","article-title":"Relationship between uveitis and the differential reactivity of retinal microglia","volume":"66","author":"Gao","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejpb.2025.114691_b0065","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1073\/pnas.1820387116","article-title":"Retinal microglia initiate neuroinflammation in ocular autoimmunity","volume":"116","author":"Okunuki","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.ejpb.2025.114691_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114108","article-title":"A combination of inhibiting microglia activity and remodeling gut microenvironment suppresses the development and progression of experimental autoimmune uveitis","volume":"180","author":"Zhou","year":"2020","journal-title":"Biochem.Pharmacol"},{"key":"10.1016\/j.ejpb.2025.114691_b0075","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/molecules22010134","article-title":"Therapeutic Potential of Targeting the Th17\/Treg Axis in Autoimmune Disorders","volume":"22","author":"Fasching","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2025.114691_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109565","article-title":"T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches","volume":"114","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ejpb.2025.114691_b0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","article-title":"Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides","volume":"612","author":"Yang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejpb.2025.114691_b0090","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejpb.2025.114691_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2025.114691_b0100","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1167\/iovs.07-0286","article-title":"Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy","volume":"48","author":"Gregerson","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2025.114691_b0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10384-011-0064-9","article-title":"Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells","volume":"55","author":"Sugita","year":"2011","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114691_b0110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1167\/iovs.15-17578","article-title":"Interleukin-17A Induces IL-1\u03b2 Secretion From RPE Cells Via the NLRP3 Inflammasome","volume":"57","author":"Zhang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2025.114691_b0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","article-title":"Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials","author":"Dick","year":"2013","journal-title":"Ophthalmology 120"},{"key":"10.1016\/j.ejpb.2025.114691_b0120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","article-title":"AIN457A2208 Study Group, Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy","volume":"122","author":"Letko","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2025.114691_b0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acsnano.2c05824","article-title":"Highly Retina-Permeating and Long-Acting Resveratrol\/Metformin Nanotherapeutics for Enhanced Treatment of Macular Degeneration","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114691_b0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/pharmaceutics13020176","article-title":"An Injectable Nano-Enabled Thermogel to Attain Controlled Delivery of p11 Peptide for the Potential Treatment of Ocular Angiogenic Disorders of the Posterior Segment","volume":"13","author":"du Toit","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114691_b0135","article-title":"Robust drug bioavailability and safety for rheumatoid arthritis therapy using D-amino acids-based supramolecular hydrogels","volume":"15","author":"Ma","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ejpb.2025.114691_b0140","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.7150\/thno.53139","article-title":"Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis","volume":"11","author":"Feng","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ejpb.2025.114691_b0145","first-page":"185","article-title":"Self-assembly of a ibuprofen-peptide conjugate to suppress ocular inflammation, Nanomedicine: Nanotechnology","volume":"14","author":"Yu","year":"2018","journal-title":"Biology and Medicine"},{"key":"10.1016\/j.ejpb.2025.114691_b0150","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1039\/c2nr31149f","article-title":"Short-peptide-based molecular hydrogels: novel gelation strategies and applications for tissue engineering and drug delivery","volume":"4","author":"Wang","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2025.114691_b0155","doi-asserted-by":"crossref","unstructured":"A.L.Z. Lee, N. Balakrishnan, J.Y. Ng, S. Liu, Z.Y. Ong, Y. Wang, S. Gao, Y.Y. Yang, Injectable Hydrogels Prepared Using Novel Synthetic Short Peptides with Defined Structure and Gelatin as Scaffolds to Support Cell and Tissue Growth, Adv Healthc Mater (2023) e2302786. https:\/\/doi.org\/10.1002\/adhm.202302786.","DOI":"10.1002\/adhm.202302786"},{"key":"10.1016\/j.ejpb.2025.114691_b0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/pharmaceutics15010205","article-title":"Ocular Delivery of Therapeutic Proteins: A Review","volume":"15","author":"Shastri","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114691_b0165","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/vaccines10010130","article-title":"Immune Enhancement by the Tetra-Peptide Hydrogel as a Promising Adjuvant for an H7N9 Vaccine against Highly Pathogenic H7N9 Virus","volume":"10","author":"Wu","year":"2022","journal-title":"Vaccines (basel)"},{"key":"10.1016\/j.ejpb.2025.114691_b0170","first-page":"1","article-title":"Current Insights into Targeting Strategies for the Effective Therapy of Diseases of the Posterior Eye Segment","volume":"41","author":"Pimple","year":"2024","journal-title":"CritRevTherDrugCarrierSyst"},{"key":"10.1016\/j.ejpb.2025.114691_b0175","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12951-023-01974-4","article-title":"Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy","volume":"21","author":"Wei","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.ejpb.2025.114691_b0180","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2022.03.011","article-title":"Enzyme-instructed self-assembly of peptide-drug conjugates in tear fluids for ocular drug delivery","volume":"344","author":"Hu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114691_b0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jconrel.2024.12.052","article-title":"D-peptide hydrogels as a long-acting multipurpose drug delivery platform for combined contraception and HIV prevention","volume":"379","author":"Pentlavalli","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114691_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304287","article-title":"Versatile Mechanically Tunable Hydrogels for Therapeutic Delivery Applications","volume":"13","author":"Sun","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejpb.2025.114691_b0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0301-4738.156914","article-title":"Experimental autoimmune uveitis and other animal models of uveitis: An update","volume":"63","author":"Bansal","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2025.114691_b0200","first-page":"155","article-title":"Understanding autoimmunity in the eye: from animal models to novel therapies","volume":"17","author":"Caspi","year":"2014","journal-title":"Discov. Med."},{"key":"10.1016\/j.ejpb.2025.114691_b0205","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201601776","article-title":"A Powerful CD8+ T-Cell Stimulating D-Tetra-Peptide Hydrogel as a Very Promising Vaccine Adjuvant","volume":"29","author":"Luo","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2025.114691_b0210","article-title":"Retinal Microenvironment-Protected Rhein-GFFYE Nanofibers Attenuate Retinal Ischemia-Reperfusion Injury via Inhibiting Oxidative Stress and Regulating Microglial\/Macrophage M1\/M2 Polarization","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci (weinh)"},{"key":"10.1016\/j.ejpb.2025.114691_b0215","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.2147\/IJN.S109986","article-title":"Visual tracing of diffusion and biodistribution for amphiphilic cationic nanoparticles using photoacoustic imaging after ex vivo intravitreal injections","volume":"11","author":"Xu","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2025.114691_b0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.02.003","article-title":"The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models","volume":"65","author":"Diedrichs-M\u00f6hring","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ejpb.2025.114691_b0225","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ajpath.2020.09.004","article-title":"Characterization of Clinical and Immune Responses in an Experimental Chronic Autoimmune Uveitis Model","volume":"191","author":"Fan","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2025.114691_b0230","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejpb.2025.114691_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.004","article-title":"Annexin-A1 restricts Th17 cells and attenuates the severity of autoimmune disease","volume":"58","author":"Yazid","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.ejpb.2025.114691_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.154994","article-title":"Interleukin-17 mRNA expression and serum levels in Beh\u00e7et\u2019s disease","author":"Jadideslam","year":"2020","journal-title":"Cytokine 127"},{"key":"10.1016\/j.ejpb.2025.114691_b0245","first-page":"32","article-title":"Up-regulation of Th17 and related cytokines in Beh\u00e7et\u2019s disease corresponding to disease activity","volume":"31","author":"Na","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ejpb.2025.114691_b0250","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/ceo.13922","article-title":"Secukinumab in HLA-B27 associated uveitis","volume":"49","author":"Miserocchi","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ejpb.2025.114691_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114917","article-title":"Ganciclovir attenuates the onset and progression of experimental autoimmune uveitis by inhibiting infiltration of Th17 and inflammatory cells into the retina","volume":"197","author":"Zhou","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2025.114691_b0260","article-title":"The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114691_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102297","article-title":"Icariin alleviates uveitis by targeting peroxiredoxin 3 to modulate retinal microglia M1\/M2 phenotypic polarization","volume":"52","author":"Wang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejpb.2025.114691_b0270","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5115\/acb.21.227","article-title":"Blood-retina barrier dysfunction in experimental autoimmune uveitis: the pathogenesis and therapeutic targets","volume":"55","author":"Kim","year":"2022","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.ejpb.2025.114691_b0275","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41390-019-0612-4","article-title":"Association of apoptosis genes in PDCD1 but not PDCD1LG2, FAS, and FASLG with pediatric idiopathic uveitis in Han Chinese","volume":"87","author":"Pang","year":"2020","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ejpb.2025.114691_b0280","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fimmu.2018.01713","article-title":"Aryl Hydrocarbon Receptor Regulates Apoptosis and Inflammation in a Murine Model of Experimental Autoimmune Uveitis","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Immunol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:39:04Z","timestamp":1762331944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125000670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":56,"alternative-id":["S0939641125000670"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114691","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptide-based hydrogel co-assembled with antibody-drug for enhanced retinal cell uptake and attenuated experimental autoimmune uveitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114691"}}